Angiotensin Receptor-Neprilysin Inhibition (ARNI) in Heart Failure
Open Access
- 24 March 2020
- journal article
- review article
- Published by XMLink in International Journal of Heart Failure
- Vol. 2 (2) , 73-90
Abstract
Greenberg B. Int J Heart Fail. 2020 Mar;2:e9. https://doi.org/10.36628/ijhf.2020.0002Keywords
This publication has 55 references indexed in Scilit:
- Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trialEuropean Heart Journal, 2011
- Hemodynamic Determinants of Myocardial B-Type Natriuretic Peptide ReleaseHypertension, 2010
- Neutral Endopeptidase Inhibition Augments Vascular Actions of Bradykinin in Patients Treated With Angiotensin-Converting Enzyme InhibitionHypertension, 2004
- Adrenomedullin (ADM) in the human forearm vascular bed: effect of neutral endopeptidase inhibition and comparison with proadrenomedullin NH2‐terminal 20 peptide (PAMP)British Journal of Clinical Pharmacology, 2001
- Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodelingJACC, 2000
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart FailureCirculation, 1996
- Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart FailureJAMA, 1995
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).Circulation, 1990